FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.
Shares of wellness-product platform Hims & Hers Health Inc. tumbled on Friday after the Food and Drug Administration said the shortage of GLP-1 medications like Ozempic and Wegovy had been “resolved” — a move that threatens alternatives to those ...
Ozempic, Wegovy Shortage Is Officially Over
The shortage of semaglutide injections (Ozempic, Wegovy) is over, the FDA announced on Friday. The agency, along with maker Novo Nordisk, confirmed that supply now meets or exceeds both the current and projected U.S. demand. The injectable formulation of the GLP-1 receptor agonist has been in shortage since August 2022 due to increased demand.
Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug ...
In this photo illustration, boxes of the diabetes drug Ozempic rest on a pharmacy counter on April 17, 2023 in Los Angeles, ...
The resolution could potentially restrict how telehealth programs offer cheaper versions known as compounded drugs ...
American demand for weight-loss drugs is supercharging Denmark’s economy and transforming a small Danish community into an ...
Semaglutide — the active substance in Ozempic and Wegovy — may help reduce alcohol cravings in people with alcohol use ...
People using semaglutide for diabetes or weight loss have also reported experiencing a reduced desire for alcohol. A new ...
A new case study is the latest to suggest that GLP-1 therapy can tamp down people's unhealthy cravings of drugs like alcohol ...
Some workers are willing to trade vacation days or go back to the office in exchange for weight-loss drug coverage by their ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback